Sign-up here for the COBO-Q Newsletter and receive the latest updates within Quality Control Genome Editing.
We are excited to announce our new partnership with SCIEX for our proteomic expression analysis platform, PIPPR powered by SWATH LC-MS.
We are excited to launch COBO-Q - the first newsletter with focus on news and updates within Quality Control Genome Editing.
We are happy to share with you the launch of the powerful PROFILase 2x Master Mix - optimised for INDEL analysis using the IDAA method.
In the News
"Keep an eye on our Network Member, the Danish biotech company Cobo Technologies - potential to influence future drug development"
Great presentation by Roberto Nitsch, Safety Director, AstraZeneca at the NIST - Genome Editing Consortium Workshop 3rd May 2019 in US, on the idea behind their PIPPR project to understand the impact of CRISPR Base-Editors (ABE) on proteomic level.
We are looking forward to meet all the members of the NIST - Genome Editing Consortium in US May 3rd. Our Co-founder and Scientific Advisor, Eric Paul Bennett and COO, Hasse Herlevsen will attend.
To further strengthen our expertise within the Quality Control field, Hasse Herlevsen (former Corp. VP Quality, LEO Pharma) will join our team as COO.
We are excited to announce that we have become member of the NIST - Genome Editing Consortium in US.